Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real‐life data
Reported median overall survival (mOS) in metastatic colorectal cancer (mCRC) patients participating in systemic therapy trials has increased to over 30 months. It is uncertain whether trial results translate to real‐life populations. Moreover, patients prefer presentation of multiple survival scena...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Text |
| Language: | English |
| Published: |
John Wiley & Sons, Inc.
2020
|
| Subjects: | |
| Online Access: | https://pmc.ncbi.nlm.nih.gov/articles/PMC7754475/ https://pubmed.ncbi.nlm.nih.gov/32638384 http://dx.doi.org/10.1002/ijc.33200 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|